ortho-cept has been researched along with Polycystic Ovary Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersen, M; Christensen, MMH; Glintborg, D; Pedersen, AJT; Stage, TB | 1 |
| Altinok, ML; Andersen, M; Bruun, JM; Glintborg, D; Mumm, H; Richelsen, B | 1 |
2 trial(s) available for ortho-cept and Polycystic Ovary Syndrome
| Article | Year |
|---|---|
The Pharmacogenetics of Metformin in Women with Polycystic Ovary Syndrome: A Randomized Trial.
Topics: Adult; Ataxia Telangiectasia Mutated Proteins; Biomarkers; Blood Glucose; Contraceptives, Oral, Hormonal; Desogestrel; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hepatocyte Nuclear Factor 1-alpha; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Metformin; Organic Anion Transport Protein 1; Organic Cation Transport Proteins; Pharmacogenetics; Pharmacogenomic Variants; Polycystic Ovary Syndrome; Time Factors; Treatment Outcome; Triglycerides; Weight Loss; Young Adult | 2018 |
Adiponectin, interleukin-6, monocyte chemoattractant protein-1, and regional fat mass during 12-month randomized treatment with metformin and/or oral contraceptives in polycystic ovary syndrome.
Topics: Abdominal Fat; Absorptiometry, Photon; Adiponectin; Adiposity; Adolescent; Adult; Body Mass Index; Chemokine CCL2; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Interleukin-6; Metformin; Obesity, Abdominal; Patient Dropouts; Polycystic Ovary Syndrome; Weight Gain; Whole Body Imaging; Young Adult | 2014 |